|
1.
|
Immune checkpoint inhibitors have shown success in treating a subset of patients with certain late-stage cancers. However, these treatments fail in many other patients, d [...]
2023-08-18 |
Abstract |
|
|
2.
|
The ability of tumors to induce immunosuppression and inhibit the cytolytic function of tumor-infiltrating lymphocytes (TIL) is a major obstacle to creating effective imm [...]
2020 |
Dissertation |
|
|
3.
|
|
|
4.
|
Immune checkpoint inhibitors have shown success in treating a subset of patients with certain late-stage cancers. However, these treatments fail in many other patients, d [...]
2024 |
Abstract |
|
|
5.
|
Monoclonal antibodies targeting key receptors that inhibit T cell function such as CTLA-4 and PD-1 have demonstrated the potency of checkpoint blockade, highlighted by lo [...]
2021 |
Thesis |
|
|
6.
|
The inability to develop an effective anti-tumor immune response plays a key role in cancer progression. Patients with a strong anti-tumor T cell response, indicated by i [...]
2016-09-01 |
Thesis |
|
|
7.
|
The majority of research on T cells forms a paradigm in which classical T cells are activated by peptide antigens presented by classical MHC molecules. Non-classical T ce [...]
2016-09-01 |
Dissertation |
|
|
8.
|
Vaccination of rhesus macaques with rhesus cytomegalovirus strain 68-1 expressing SIV proteins (RhCMV/SIV) results in stringent control of SIV replication. Approximately [...]
2016-06-01 |
Dissertation |
|
|
9.
|
|
|
10.
|
|
